Study of FasT CAR-T GC012F Injection NDMM Patients

Clinical trial NCT05840107 · UNKNOWN

Trial details

NCT number: NCT05840107
Sponsor: Shanghai Changzheng Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2023-05-04
Primary completion: 2025-09-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.